India to United States: Ipratropium Export Trade Route

The India to United States Ipratropium corridor is one of India's established pharmaceutical export routes, with 341 shipments documented worth a combined $14.8M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 85% of all export value, reflecting the consolidated nature of India's ipratropium manufacturing sector.

Across 7 active suppliers, the average shipment value stands at $43.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with ipratropium's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 22 days port-to-port. The route has recorded an annual growth rate of 27.5%, placing it at rank #12 among India's top ipratropium export destinations globally.

On the import side, key buyers of Indian ipratropium in United States include CIPLA USA INC UPS SUPPLY CHAIN SOLU, SUN PHARMACEUTICAL INDUSTRIES,INC., SUN PHARMACEUTICAL INDUSTRIES INC and 7 others. CIPLA USA INC UPS SUPPLY CHAIN SOLU is the single largest importer with 184 shipments valued at $12.3M USD.

India's ipratropium exports to United States are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 197 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CIPLA LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, RUBICON RESEARCH LIMITED — together account for 98% of total trade value on this route. The average shipment value of $43.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as ipratropium bromide and albuterol sulfate inhalation solution 0.5mg & 3mg/3ml; [pac size:12x5x3mlx8484 pac=509040 nos] and ipratropium bromide and albuterol sulfate inhalation solution 0.5mg & 3mg/3ml; ndc no. 6909717353; anda no. :#077559 pac, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, CIPLA USA INC UPS SUPPLY CHAIN SOLU is the largest importer with 184 shipments worth $12.3M USD — representing 83% of all ipratropium imports from India on this route. A total of 10 buyers are active on this corridor.